Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TK216 + YK-4-279 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TK216 | TK-216|TK 216 | TK216 binds to and inhibits Ets-family transcription factor, which may lead to anti-tumor effects (PMID: 31182435). | ||
YK-4-279 | YK-4-279 is a small molecule inhibitor of the ETS transcription factors, ERG and ETV1, which may result in inhibition of cell mobility and invasion (PMID: 21559405, PMID: 32016454). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|